These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 23839001

  • 1. Regulatory T cells are not predictive of outcomes in a nonhuman primate model of vascularized composite allotransplantation.
    Brazio PS, Munivenkatappa RB, Bojovic B, Ha JS, Brown EN, Hess AS, Bartlett ST, Rodriguez ED, Barth RN.
    Transplantation; 2013 Aug 15; 96(3):267-73. PubMed ID: 23839001
    [Abstract] [Full Text] [Related]

  • 2. Lymphoid neogenesis in skin of human hand, nonhuman primate, and rat vascularized composite allografts.
    Hautz T, Zelger BG, Nasr IW, Mundinger GS, Barth RN, Rodriguez ED, Brandacher G, Weissenbacher A, Zelger B, Cavadas P, Margreiter R, Lee WP, Pratschke J, Lakkis FG, Schneeberger S.
    Transpl Int; 2014 Sep 15; 27(9):966-76. PubMed ID: 24853399
    [Abstract] [Full Text] [Related]

  • 3. Syngeneic adipose-derived stem cells with short-term immunosuppression induce vascularized composite allotransplantation tolerance in rats.
    Cheng HY, Ghetu N, Huang WC, Wang YL, Wallace CG, Wen CJ, Chen HC, Shih LY, Lin CF, Hwang SM, Liao SK, Wei FC.
    Cytotherapy; 2014 Mar 15; 16(3):369-80. PubMed ID: 24119648
    [Abstract] [Full Text] [Related]

  • 4. Unraveling the Crucial Roles of FoxP3+ Regulatory T Cells in Vascularized Composite Allograft Tolerance Induction and Maintenance.
    Anggelia MR, Cheng HY, Chuang WY, Hsieh YH, Wang AYL, Lin CH, Wei FC, Brandacher G, Lin CH.
    Transplantation; 2021 Jun 01; 105(6):1238-1249. PubMed ID: 33141809
    [Abstract] [Full Text] [Related]

  • 5. Histopathology of chronic rejection in a nonhuman primate model of vascularized composite allotransplantation.
    Mundinger GS, Munivenkatappa R, Drachenberg CB, Ha JS, Vaca EE, Shipley ST, Papadimitriou JC, Bartlett ST, Rodriguez ED, Barth RN.
    Transplantation; 2013 May 27; 95(10):1204-10. PubMed ID: 23694932
    [Abstract] [Full Text] [Related]

  • 6. Limited efficacy of rapamycin monotherapy in vascularized composite allotransplantation.
    Xu H, Steinberger Z, Wang L, Han R, Zhang Y, Hancock WW, Levin LS.
    Transpl Immunol; 2020 Aug 27; 61():101308. PubMed ID: 32535143
    [Abstract] [Full Text] [Related]

  • 7. Bioimaging of alloantigen-stimulated regulatory T cells in rat vascularized composite allotransplantation.
    Cheng HY, Tay SKL, Wen CJ, Lin CF, Wang AY, Shih LY, Liu SC, Kobayashi E, Lin CH, Wei FC.
    PLoS One; 2018 Aug 27; 13(9):e0203624. PubMed ID: 30192879
    [Abstract] [Full Text] [Related]

  • 8. Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival.
    Wolf D, Schreiber TH, Tryphonopoulos P, Li S, Tzakis AG, Ruiz P, Podack ER.
    Transplantation; 2012 Sep 27; 94(6):569-74. PubMed ID: 22902792
    [Abstract] [Full Text] [Related]

  • 9. Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.
    Olariu R, Denoyelle J, Leclère FM, Dzhonova DV, Gajanayake T, Banz Y, Hayoz M, Constantinescu M, Rieben R, Vögelin E, Taddeo A.
    J Surg Res; 2017 Oct 27; 218():49-57. PubMed ID: 28985877
    [Abstract] [Full Text] [Related]

  • 10. Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates.
    Barth RN, Rodriguez ED, Mundinger GS, Nam AJ, Ha JS, Hui-Chou H, Jones LS, Panda A, Shipley ST, Drachenberg CB, Kukuruga D, Bartlett ST.
    Am J Transplant; 2011 Jul 27; 11(7):1407-16. PubMed ID: 21668624
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous transplantation of hematopoietic stem cells and a vascularized composite allograft leads to tolerance.
    Mathes DW, Chang J, Hwang B, Graves SS, Storer BE, Butts-Miwongtum T, Sale GE, Storb R.
    Transplantation; 2014 Jul 27; 98(2):131-8. PubMed ID: 24918616
    [Abstract] [Full Text] [Related]

  • 12. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
    Demirkiran A, Kok A, Kwekkeboom J, Kusters JG, Metselaar HJ, Tilanus HW, van der Laan LJ.
    Liver Transpl; 2006 Feb 27; 12(2):277-84. PubMed ID: 16447185
    [Abstract] [Full Text] [Related]

  • 13. The number of regulatory T cells in transbronchial lung allograft biopsies is related to FoxP3 mRNA levels in bronchoalveolar lavage fluid and to the degree of acute cellular rejection.
    Krustrup D, Madsen CB, Iversen M, Engelholm L, Ryder LP, Andersen CB.
    Transpl Immunol; 2013 Dec 27; 29(1-4):71-5. PubMed ID: 23969200
    [Abstract] [Full Text] [Related]

  • 14. Diagnosing skin rejection in vascularized composite allotransplantation: advances and challenges.
    Sarhane KA, Khalifian S, Ibrahim Z, Cooney DS, Hautz T, Lee WP, Schneeberger S, Brandacher G.
    Clin Transplant; 2014 Mar 27; 28(3):277-85. PubMed ID: 24476538
    [Abstract] [Full Text] [Related]

  • 15. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
    Kueckelhaus M, Fischer S, Seyda M, Bueno EM, Aycart MA, Alhefzi M, ElKhal A, Pomahac B, Tullius SG.
    Transpl Int; 2016 Jun 27; 29(6):655-62. PubMed ID: 26265179
    [Abstract] [Full Text] [Related]

  • 16. Time elapsed after transplantation influences the relationship between the number of regulatory T cells in lung allograft biopsies and subsequent acute rejection episodes.
    Krustrup D, Iversen M, Martinussen T, Andersen CB.
    Transpl Immunol; 2014 Jun 27; 31(1):42-7. PubMed ID: 24801207
    [Abstract] [Full Text] [Related]

  • 17. Local Immunosuppression for Vascularized Composite Allografts: Application of Topical FK506-TyroSpheres in a Nonhuman Primate Model.
    Gama AR, Ng ZY, Shanmugarajah K, Mastroianni M, Randolph MA, Lellouch AG, Kohn J, Cetrulo CL.
    J Burn Care Res; 2020 Nov 30; 41(6):1172-1178. PubMed ID: 32352521
    [Abstract] [Full Text] [Related]

  • 18. Prolonged survival of composite facial allografts in non-human primates associated with posttransplant lymphoproliferative disorder.
    Barth RN, Nam AJ, Stanwix MG, Kukuruga D, Drachenberg CI, Bluebond-Langner R, Hui-Chou H, Shipley ST, Bartlett ST, Rodriguez ED.
    Transplantation; 2009 Dec 15; 88(11):1242-50. PubMed ID: 19996923
    [Abstract] [Full Text] [Related]

  • 19. Th17 cell inhibition in a costimulation blockade-based regimen for vascularized composite allotransplantation using a nonhuman primate model.
    Atia A, Moris D, McRae M, Song M, Stempora L, Leopardi F, Williams K, Kwun J, Parker W, Cardones AR, Kirk AD, Cendales LC.
    Transpl Int; 2020 Oct 15; 33(10):1294-1301. PubMed ID: 32277724
    [Abstract] [Full Text] [Related]

  • 20. Mucosa and Rejection in Facial Vascularized Composite Allotransplantation: A Systematic Review.
    Kauke M, Safi AF, Zhegibe A, Haug V, Kollar B, Nelms L, Palmer WJ, Tchiloemba B, Lian CG, Murphy GF, Pomahac B.
    Transplantation; 2020 Dec 15; 104(12):2616-2624. PubMed ID: 32053572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.